We are live on
!
Find out more
TCM
Tao Capital Management Portfolio holdings
AUM
$119M
1-Year Est. Return
87.46%
This Fund
S&P 500
This Quarter
Est. Return
-5.06%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$11.6M
(-9.5%)
Cap. Flow
-$16
Cap. Flow
% of AUM
-0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$10 |
| 2 |
BHIL
Benson Hill, Inc.
BHIL
|
+$6 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.82% |
| 2 | Consumer Discretionary | 30.43% |
| 3 | Technology | 6.42% |
| 4 | Consumer Staples | 0.33% |
Similar funds
SF
MWM
VA
HPM
SKK
WKSWA
CA
LC
Tao Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Tao Capital Management held 10 positions worth $110M, down 9.5% from $122M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 0%. Tao Capital Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 68% a quarter earlier, followed by Consumer Discretionary and Technology.
- Tao Capital Management's biggest Q3 2024 reduction was Ginkgo Bioworks, cutting an estimated $10.
- Tao Capital Management's ten largest holdings make up 100% of its $110M portfolio in Q3 2024.
- Tao Capital Management opened 0 new positions and closed 0 in Q3 2024.
- Tao Capital Management's portfolio value fell 9.5% quarter-over-quarter to $110M.
Based on Tao Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.